XORTX Therapeutics Inc.

Developing late-stage, uric acid-lowering therapies for gout and progressive kidney disease.

XRTX | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: SUITE 2400 - 745 THURLOW STREET, VANCOUVER
Website:: https://www.xortx.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

XORTX Therapeutics Inc. is a late-stage clinical pharmaceutical company focused on developing first-in-class, uric acid-lowering agents. The company's therapeutic pipeline targets diseases modulated by aberrant purine and uric acid metabolism, primarily focusing on gout and progressive kidney diseases. Its lead programs include XRx-026 for gout patients unresponsive to standard care, which is at the pre-New Drug Application (NDA) filing stage. Other key development programs are XRx-008 for autosomal dominant polycystic kidney disease (ADPKD), XRx-101 for acute kidney disease, and XRx-225 for Type 2 Diabetic Nephropathy (T2DN). XORTX actively pursues strategic collaborations to develop and commercialize its novel therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all XORTX Therapeutics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for XORTX Therapeutics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for XORTX Therapeutics Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Adtraction Group AB A partner marketing platform driving online sales for brands with a performance-based model.	Sweden	ADTR
Adventure, Inc. A Japanese OTA providing competitive rates for global travel bookings in over 30 languages.	Japan	6030
Adverty AB Adtech platform for seamless, non-intrusive brand advertising in games, AR, and VR.	Sweden	ADVT
Adways Inc. Global mobile marketing firm providing ad tech and agency services, focused on Asian markets.	Japan	2489
AerCap Holdings N.V. Global leader in leasing aircraft, engines, and helicopters to airlines worldwide.	United States of America	AER
Aidma Marketing Communication Corporation Data-driven sales promotions for the retail industry, offering both digital and print solutions.	Japan	9466
AIR LEASE CORP Leases new commercial aircraft to airlines worldwide, offering financing and fleet management.	United States of America	AL
All About,Inc. Japanese digital media group connecting businesses and consumers via e-commerce and product sampling.	Japan	2454
Altimmune, Inc. Developing novel peptide therapeutics for obesity, liver, and cardiometabolic diseases.	United States of America	ALT
AlzeCure Pharma Develops small-molecule drug therapies for Alzheimer's, pain, and cognitive dysfunction.	Sweden	ALZCUR